FDA Import Refusal AEK-9670993-4/10002/1 — CAPLIN POINT LABORATORIES LTD
The FDA refused shipment AEK-9670993-4/10002/1 from CAPLIN POINT LABORATORIES LTD (India) on Sep 3, 2026. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75